kotak-logo
Open Demat Account

I

Indira IVF IPO

-- / --

Indira IVF IPO Details

Issue Date

--

Price Range

--

Lot Size

--

IPO Size

N/A

Schedule of Indira IVF IPO

Start date

End date

Allotment of bids

Refund Initiation

Listing on exchange

About Indira IVF IPO

Fertility services provider Indira IVF, which had filed papers with SEBI through the confidential route for its IPO, has received approval from the regulator. The issue size and price band of shares in the IPO are [TBA].

Indira IVF IPO opens on [TBA] and closes on [TBA]. The allotment of shares will take place on [TBA]. The credit of shares to the Demat account will take place on [TBA]. The initiation of refunds will take place on [TBA].

The listing of shares will take place on [TBA]. The lot size of shares in the IPO is [TBA]. The minimum investment amount required by a retail investor is ₹ [TBA] based on the upper price. The minimum lot for retail investors in this IPO is [TBA].

Indira IVF is not just a network of fertility clinics. It is a community built on hope. With 165+ centres across India, a compassionate team of 340+ IVF specialists, and advanced medical technology, Indira IVF offers personalised care to couples looking to conceive.

Objectives of Indira IVF IPO

TBA

Indira IVF IPO Valuation

Indira IVF IPO Lot Size

Indira IVF IPO Offer and Subscription Details

Industry Outlook

According to the latest market research by the CMI team, India’s IVF services market is poised for strong growth, with a projected CAGR of 16.23% between 2025 and 2034. The market is estimated to be valued at USD 1,410.11 million in 2025 and is expected to expand significantly to reach USD 4,915.01 million by 2034.

Indira IVF Company Information

Indira IVF is not just a network of fertility clinics. It’s a community built on hope and care. With over 165 centres across India, its journey is led by a dedicated team of 340+ IVF specialists who combine compassion with cutting-edge technology.

It stands beside every family with personalised treatment and unwavering support. Rooted in science and driven by hope, it’s honoured to have been part of more than 1,75,000 successful pregnancies.

Strengths of Indira IVF

  • Strong business profile characterised by established brand position in the Indian IVF industry and vast experience of promoters
  • Robust financial profile

Risks of Indira IVF

TBA

Comparison with peers

Anchor Investor Bidding Date

TBA

IPO Registrar and Book Running Lead Manager

  • IPO Registrar: TBA
  • Book Running Lead Managers: TBA

Business Model

Indira IVF offers a range of fertility treatments, including IVF, IUI, ICSI, etc. It also offers advanced treatments such as DFI, PGT-A, and PLI, among others. It also conducts donor programmes and conducts infertility testing, among others.

Indira IVF Growth Trajectory

Founded as a single stand-alone hospital in 2011, Indira IVF grew to 94 centres by 2021 and achieved over 75,000 successful IVF pregnancies. The organisation recorded a 100% increase in pregnancies over the past three years. It attributes its growth attributes to rapid network expansion and a strong, data-driven operating model.

The company’s operating income grew from ₹1476.4 crores in FY 24 to 1604.5 in FY 25. Its PAT increased from ₹266.2 crores in FY 24 to ₹297.8 in FY 25.

Indira IVF Market Position

Indira IVF has 165+ centres across India. It has a PAN-India presence across cities such as Pune, Patna, Ludhiana, Bengaluru, Delhi, Bhopal, and Kolkata. Its operating philosophy is centred around “Awareness”, “Accessibility” and “Reliability”. It has 340 plus IVF doctors.

Indira IVF Profit and Loss (in ₹ crores)

Indira IVF Balance Sheet (in ₹ crores)

How to Apply for the Indira IVF IPO?

To apply for this IPO:

  • Log in to your Kotak Neo Demat account: Log in to your Demat account to access IPO investments. Next, select the current IPO section.
  • Specify IPO details: Enter the number of lots and the price you wish to apply for.
  • Enter UPI ID: After entering your UPI ID, click submit. This will place your bid with the exchange.
  • Mandate Notification: Your UPI app will receive a mandate notification to block funds.
  • Approve Request: Your funds will be blocked once you approve the mandate request on your UPI.

Indira IVF IPO FAQs

The Indira IVF IPO opens for subscription from [-] to [-], with a total issue size of [-]. The IPO price band is ₹[-] per share with a lot size of [-]. The company aims to list the shares on BSE & NSE on [-].

The Indira IVF IPO will open for subscription on [-] and will close on [-] for investors.

The minimum lot size for the Indira IVF IPO is [-] equity shares, requiring a minimum investment of ₹[-] for retail investors applying in the IPO.

The price band of the Indira IVF IPO has been fixed at ₹[-] per equity share.

You can apply for the Indira IVF IPO online through the Kotak Neo Website or the Kotak Neo App using UPI or ASBA during the IPO subscription period.

Indira IVF IPO allotment will take place on [-].

You can check the Indira IVF IPO allotment status online on the registrar’s website or on the NSE and BSE IPO allotment pages using your application number, PAN, or demat account details.

Indira IVF shares will list on the stock exchanges on [-].

The exact dates of the IPO are yet to be known.

Kshitiz Murdia is the CEO of Indira IVF.

The lot size of shares in this IPO is [TBA].

You can read more about Indira IVF and its IPO from the company’s draft red herring prospectus here.

This article is for informational purposes only and does not constitute financial advice. It is not produced by the desk of the Kotak Neo Research Team, nor is it a report published by the Kotak Neo Research Team. The information presented is compiled from several secondary sources available on the internet and may change over time. Investors should conduct their own research and consult with financial professionals before making any investment decisions. Read the full disclaimer here.

Investments in securities market are subject to market risks, read all the related documents carefully before investing. Brokerage will not exceed SEBI prescribed limit. The securities are quoted as an example and not as a recommendation. SEBI Registration No-INZ000200137 Member Id NSE-08081; BSE-673; MSE-1024, MCX-56285, NCDEX-1262.

Trending IPOs